Skip to content

Docteur Pierre DELVOYE

Active Private limited companyfounded 2023active for 3 yearsAvenue des Ormes 7, 4130 EsneuxKBO/BCE: BE 0802.391.522

Lifetime

3 annual accounts with figures on one time axis
peak of €40,495 in 2025
€40,495▲ 15.1%
peak of €29,883 in 2025
€29,883▲ 35.0%
peak of €42,198 in 2024
€4,081▼ 90.3%
€76,121▲ 959%
Board1 name since 2023
1 director
Documentsfilings and deeds
13-07-202618 days before the deadline
2025micro format
Gross margin from €35,183 to €40,495Result from €22,140 to €29,883Dividend €68,000Equity from €42,198 to €4,081Debts from €7,191 to €76,121Cash from €39,487 to €68,749

Key points

from the 2025 annual accounts

Equity

€4,081 ▼ 90.3%
42,1982024+29,883Profit-68,000Dividend4,0812025

Docteur Pierre DELVOYE paid out €68,000 in dividends. That is 228% of the 2025 profit.

Turnover

≈ €120,000 estimated

The micro format states no turnover.

Debts

€76,121 95% of the balance sheet
Suppliers 3%Taxes and wages 23%Other 75%

Of this, €76,048 falls due within a year.

Liquidity

1.01 was 6.25 in 2024

Short-term debts rose from €7,191 to €76,048.

Position in the sector

€4,081

Less equity than 92% of companies in human health. The sector median is €125,219, over 21,370 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,155 companies had the same profile as Docteur Pierre DELVOYE has now. Each dot stands for 6 companies, two years later.

94.1%
were still trading
2.8%
stopped another way
3.0%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,155 companies, not a prediction for Docteur Pierre DELVOYE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 07-06-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0802391522
Incorporation Founding capital of €2,500, 100 shares · Founded by · appointed as director · published on 07-06-2023 · Gazette deed
First establishment Avenue des Ormes 7, Esneux
All 7 events

Comparable companies

same main activity, similar in size and age
Company
Docteur Pierre DELVOYE Esneux €80,202 €40,495 5.1% -
Camille SCHNACKERS Verviers €84,968 €37,842 87.3% -
Docteur Marie-Christine FAILLA Blegny €95,763 €39,457 3.1% -
Medesi Hasselt €77,513 €41,718 94.1% -
GYNESIA Anderlecht €79,711 €39,288 56.8% -
LARYS MED Namur €91,112 €41,963 94.9% -
MGP Santé Honnelles €87,109 €43,915 47.7% -

These companies have the same main activity as Docteur Pierre DELVOYE: general medical practice (NACE 86210). They are comparable in size and age: total assets between €77,500 and €95,800, founded in 2023.

Official details

Source: KBO
Status
Active since 05-06-2023Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.345.985.3824130 Esneux, since 05-06-2023
Financial year end
31 December
Peppol
Reachable since 01-12-2025
Company details

Annual accounts 2025

€80,202▲ 62.4%
Filing
Filed on 13-07-2026, 18 days before the end of the filing period
Financials

Insights on Docteur Pierre DELVOYE

Docteur Pierre DELVOYE files the micro format. That format states no turnover. The gross margin rose from €22,669 in 2023 to €40,495 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Docteur Pierre DELVOYE

What is the company number of Docteur Pierre DELVOYE?
The company number of Docteur Pierre DELVOYE is 0802.391.522. The VAT number is the same number with BE in front: BE 0802.391.522.
Where is Docteur Pierre DELVOYE based?
The registered office is at Avenue des Ormes 7, 4130 Esneux.Company details
What does Docteur Pierre DELVOYE do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Docteur Pierre DELVOYE?
Docteur Pierre DELVOYE is a private limited company (BV).
When was Docteur Pierre DELVOYE founded?
Docteur Pierre DELVOYE was founded on 05-06-2023.
Is Docteur Pierre DELVOYE still active?
Yes, Docteur Pierre DELVOYE is an active enterprise in the KBO register.
What is the turnover of Docteur Pierre DELVOYE?
The turnover in financial year 2025 is about €120,000. This figure is estimated from the gross margin of €40,495 and 47 comparable companies (NACE 86). It probably lies between €90,000 and €180,000.Financials
Is Docteur Pierre DELVOYE profitable?
In financial year 2025, Docteur Pierre DELVOYE made a profit of €29,883.
Where can I find the annual accounts of Docteur Pierre DELVOYE?
Docteur Pierre DELVOYE filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Docteur Pierre DELVOYE due?
Docteur Pierre DELVOYE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.